417 related articles for article (PubMed ID: 26874697)
21. Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
Wang SS; Zheng M; Pang X; Zhang M; Yu XH; Wu JB; Gao XL; Wu JS; Yang X; Tang YJ; Tang YL; Liang XH
Mol Carcinog; 2019 Oct; 58(10):1809-1821. PubMed ID: 31219646
[TBL] [Abstract][Full Text] [Related]
22. Antimetastatic potentials of salvianolic acid A on oral squamous cell carcinoma by targeting MMP-2 and the c-Raf/MEK/ERK pathway.
Fang CY; Wu CZ; Chen PN; Chang YC; Chuang CY; Lai CT; Yang SF; Tsai LL
Environ Toxicol; 2018 May; 33(5):545-554. PubMed ID: 29385302
[TBL] [Abstract][Full Text] [Related]
23. Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and beta1 integrin.
Siqueira AS; Gama-de-Souza LN; Arnaud MV; Pinheiro JJ; Jaeger RG
Tumour Biol; 2010 Jan; 31(1):46-58. PubMed ID: 20237901
[TBL] [Abstract][Full Text] [Related]
24. Imbalance between MMP-2, 9 and TIMP-1 promote the invasion and metastasis of renal cell carcinoma via SKP2 signaling pathways.
Lu H; Cao X; Zhang H; Sun G; Fan G; Chen L; Wang S
Tumour Biol; 2014 Oct; 35(10):9807-13. PubMed ID: 24986570
[TBL] [Abstract][Full Text] [Related]
25. Antineoplastic activity of Newcastle disease virus strain D90 in oral squamous cell carcinoma.
Zhang CX; Ye LW; Liu Y; Xu XY; Li DR; Yang YQ; Sun LL; Yuan J
Tumour Biol; 2015 Sep; 36(9):7121-31. PubMed ID: 25877754
[TBL] [Abstract][Full Text] [Related]
26. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC
Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885
[TBL] [Abstract][Full Text] [Related]
27. Significance of oral cancer-associated fibroblasts in angiogenesis, lymphangiogenesis, and tumor invasion in oral squamous cell carcinoma.
Lin NN; Wang P; Zhao D; Zhang FJ; Yang K; Chen R
J Oral Pathol Med; 2017 Jan; 46(1):21-30. PubMed ID: 27229731
[TBL] [Abstract][Full Text] [Related]
28. Aberrant expression of beta-dystroglycan may be due to processing by matrix metalloproteinases-2 and -9 in oral squamous cell carcinoma.
Shang ZJ; Ethunandan M; Górecki DC; Brennan PA
Oral Oncol; 2008 Dec; 44(12):1139-46. PubMed ID: 18487074
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Oral Squamous Cell Carcinoma Proliferation Through Crosstalk Between SMAD7 and CYLD.
Ge WL; Xu JF; Hu J
Cell Physiol Biochem; 2016; 38(3):1209-17. PubMed ID: 26982322
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
31. PKM2 enhances cancer invasion via ETS-1-dependent induction of matrix metalloproteinase in oral squamous cell carcinoma cells.
Park YJ; Kim JY; Lee DY; Zhang X; Bazarsad S; Chung WY; Kim J
PLoS One; 2019; 14(5):e0216661. PubMed ID: 31071178
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-22 promotes the migration and invasion of oral squamous cell carcinoma cells.
Komine-Aizawa S; Aizawa S; Takano C; Hayakawa S
Immunol Med; 2020 Sep; 43(3):121-129. PubMed ID: 32546118
[TBL] [Abstract][Full Text] [Related]
33. S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9.
Sapkota D; Bruland O; Costea DE; Haugen H; Vasstrand EN; Ibrahim SO
Eur J Cancer; 2011 Mar; 47(4):600-10. PubMed ID: 21074410
[TBL] [Abstract][Full Text] [Related]
34. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
Prgomet Z; Axelsson L; Lindberg P; Andersson T
J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
[TBL] [Abstract][Full Text] [Related]
35. Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma.
Alam H; Bhate AV; Gangadaran P; Sawant SS; Salot S; Sehgal L; Dange PP; Chaukar DA; D'cruz AK; Kannanl S; Gude R; Kane S; Dalal SN; Vaidya MM
BMC Cancer; 2012 Jan; 12():32. PubMed ID: 22264292
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-205-5p suppresses the invasiveness of oral squamous cell carcinoma by inhibiting TIMP‑2 expression.
Nagai H; Hasegawa S; Uchida F; Terabe T; Ishibashi Kanno N; Kato K; Yamagata K; Sakai S; Kawashiri S; Sato H; Yanagawa T; Bukawa H
Int J Oncol; 2018 Mar; 52(3):841-850. PubMed ID: 29393341
[TBL] [Abstract][Full Text] [Related]
37. Receptor for activated C kinase 1 (RACK1): a regulator for migration and invasion in oral squamous cell carcinoma cells.
Li J; Guo Y; Feng X; Wang Z; Wang Y; Deng P; Zhang D; Wang R; Xie L; Xu X; Zhou Y; Ji N; Hu J; Zhou M; Liao G; Geng N; Jiang L; Wang Z; Chen Q
J Cancer Res Clin Oncol; 2012 Apr; 138(4):563-71. PubMed ID: 22207523
[TBL] [Abstract][Full Text] [Related]
38. [The influence of urothelial carcinoembryonic antigen 1 on invasion and migration of oral carcinoma cell lines].
Yang YT; Yang HY; Wang YF; Shen SY; Li MH; Qin JR
Zhonghua Kou Qiang Yi Xue Za Zhi; 2016 Jan; 51(1):36-41. PubMed ID: 26792186
[TBL] [Abstract][Full Text] [Related]
39. Doxorubicin combined with low intensity ultrasound suppresses the growth of oral squamous cell carcinoma in culture and in xenografts.
Fan H; Li H; Liu G; Cong W; Zhao H; Cao W; Zheng J
J Exp Clin Cancer Res; 2017 Nov; 36(1):163. PubMed ID: 29157266
[TBL] [Abstract][Full Text] [Related]
40. MMP-9 Knockdown Inhibits Oral Squamous Cell Carcinoma Lymph Node Metastasis in the Nude Mouse Tongue-Xenografted Model through the RhoC/Src Pathway.
Yin P; Su Y; Chen S; Wen J; Gao F; Wu Y; Zhang X
Anal Cell Pathol (Amst); 2021; 2021():6683391. PubMed ID: 33828938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
